Abstract:BACKGROUND Occult breast cancer (OBC) has traditionally been considered to be a carcinoma of unknown primary origin with a favorable prognosis and can be treated as stage II-III breast cancer. Due to the small number of cases and limited clinical ex-perience, treatments vary greatly around the world and no standardized treatment has yet been established. AIM To investigate the clinicopathological features, psychological status and prog-nostic features of patients with OBC. METHODS The clinicopathological data of 33 OBC patients diagnosed and treated in the Affiliated Hospital of Xuzhou Medical University and Xuzhou Central Hospital from November 2015 to November 2022 were retrospectively analyzed. The psychological status of OBC patients was evaluated by the Self-rating Anxiety Scale and Self-rating Depression Scale. Patients’ emotions, stress perception and psychological resilience were evaluated by the Positive and Negative Affect Schedule, the Chinese Perceived Stress Scale, and the Connor-Davidson Resilience Scale (CD-RISC), respectively. Patient survival was calculated using the Kaplan-Meier method, and survival curves were plotted for analysis with the log-rank test. Univariate and multivariate survival analyses were performed using the Cox regression model. RESULTS The 33 OBC patients included 32 females and 1 male. Of the 33 patients, 30 (91%) had axillary tumors, 3 (9%) had a neck mass as the primary symptom; 18 (54.5%) had estrogen receptor-positive tumors, 17 (51.5%) had progesterone receptor-positive tumors, and 18 (54.5%) had Her-2-positive tumors; 24 (72.7%) received surgical treatment, including 18 patients who underwent modified radical mastectomy, 1 patient who underwent breast-conserving surgery plus axillary lymph node dissection (ALND), and 5 patients who underwent ALND alone; 12 patients received preoperative neoadjuvant therapy. All 30 patients developed anxiety and depression, with low positive affect scores and high negative affect scores, accompanied by a high stress level and poor psychological resilience. There were no differences in the psychological status of patients according to age, body mass index, or menopausal status. The overall survival and disease-free survival (DFS) of all the patients were 83.3% and 55.7%, respectively. Univariate analysis demonstrated that the initial tumor site (P = 0.021) and node stage (P = 0.020) were factors that may affect patient prognosis. The 5-year DFS rate of OBC patients who received radiotherapy was greater (P < 0.001), while the use of different surgical methods (P = 0.687) had no statistically significant effect on patient outcomes. Multivariate analysis revealed that radiotherapy (P = 0.031) was an independent prognostic factor. Receiving radiotherapy had a significant effect on the CD-RISC score (P = 0.02). CONCLUSION OBC is a rare breast disease whose diagnosis and treatment are currently controversial. There was no significant difference in the efficacy of other less invasive surgical procedures compared to those of modified radical mastectomy. In addition, radiotherapy can significantly improve patient outcomes. We should pay attention to the psychological state of patients while they receive antitumor therapy.

Potential prognostic value of clinical characteristics, hormone status and major depressive disorder in breast cancer.

Significance of Clinical Factors As Prognostic Indicators for Mature T-Cell Non-Hodgkin Lymphoma Patients: A Retrospective Analysis of Chinese Cases

Prognostic value of baseline serum HER2 extracellular domain level with a cut-off value of 15 ng/mL in patients with breast cancer: a systematic review and meta-analysis

Clinicopathologic characteristics and prognostic significance of HER2-low expression in patients with early breast cancer: A systematic review and meta-analysis

Potential prognostic factors in progression-free survival for patients with cervical cancer

Clinicopathological features, psychological status, and prognosis of 33 patients with occult breast cancer

Prognostic value of depression and anxiety on breast cancer recurrence and mortality: a systematic review and meta-analysis of 282,203 patients

Analysis of Clinicopathologic Factors Correlating with Prognosis of 146 Cases of Breast Cancer

Prognostic value of programmed cell death ligand-1 expression in breast cancer A meta-analysis

The Discordance Pattern Of Molecular Sub-Types Between Primary And Metastatic Sites In Chinese Breast Cancer Patients

Expression and Potential Prognostic Value of Histone Family Gene Signature in Breast Cancer.

Potential Prognostic Value of the Lymph Node Ratio and Its Correlation with Circulating Sex Hormone Concentration in Pathological T1/2 Breast Cancer Patients: a Retrospective Study

The Significance of Clinical Factors Influencing the Prognosis of Patients' of Breast Cancer.

Group-based trajectory and predictors of anxiety and depression among Chinese breast cancer patients

Breast cancer promotes the expression of neurotransmitter receptor related gene groups and image simulation of prognosis model

Associations between plasma markers and symptoms of anxiety and depression in patients with breast cancer

Clinicopathological Features and Survival of Early Stage Breast Cancer in Northwest China: A Population‐based Retrospective Study of 1287 Patients

PD-1 and PD-L1 correlated gene expression profiles and their association with clinical outcomes of breast cancer

Prognostic Value Of Ki-67 In Breast Cancer Patients With Positive Axillary Lymph Nodes: A Retrospective Cohort Study

Progesterone receptor status and Ki-67 index may predict early relapse in luminal B/HER2 negative breast cancer patients: a retrospective study.

[Value of Cancer-Related Oncoprotein Expression As Prognostic Factors in Breast-Cancer with One to Three Axillary Lymph Nodes Positive].